NCT03428295View on ClinicalTrials.gov

Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC

PHASE1/PHASE2SuspendedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 22, 2017

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Glucose, Low BloodGlucose, High Blood
Interventions
DEVICE

Dose Safety AP system

Device will be used to automatically dose insulin

Trial Locations (1)

98052

Dose Safety, Redmond

Sponsors
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Benaroya Research Institute

OTHER

lead

Dose Safety Inc.

INDUSTRY